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HIGHLIGHTS 
 Systemic inflammation is associated with lower levels of physical activity 
 Regular physical activity reduces the risk of developing depressive symptoms 
 Low physical activity mediates the inflammation-depressive symptoms 
relationship 
Keywords:  Depressive symptoms, systemic low-grade inflammation, physical 
activity, mediation analysis 
 
  
 
 
ABSTRACT 
Objective: Systemic low-grade inflammation has been associated with the onset of 
depression, but the exact mechanisms underlying this relationship remain elusive.  
This study examined whether physical activity (PA) explained the association 
between elevated plasma levels of inflammatory markers and subsequent 
depressive symptoms. 
Design: Prospective cohort design. 
Method: The sample consisted of 3,809 non-depressed men and women (aged 50+) 
recruited from the English Longitudinal Study of Ageing (ELSA).  Serum levels of 
inflammatory markers (C-reactive protein (CRP), fibrinogen) and covariates (age, 
sex, education, wealth, body mass index, smoking, cholesterol, triglycerides) were 
measured at baseline (wave 4, 2008/09).  Self-reported weekly moderate/vigorous 
(high) PA versus no weekly moderate/vigorous (low) PA was examined at a four-
year follow-up (wave 6, 2012/13), using a single-item question.  Depressive 
symptoms were assessed at baseline, four years (wave 6, 2012/13) and six years 
post baseline (wave 7, 2014/15), using the 8-item version of the Centre for 
Epidemiological Studies Depression Scale (CES-D). 
Results: Participants with higher baseline concentrations of inflammatory markers 
were significantly more likely to report low PA levels four years later (CRP: OR: 1.25; 
95% CI, 1.05-1.48; fibrinogen: OR: 1.18; 95% CI, 1.05-1.39).  Moreover, low PA was 
associated with higher odds of elevated depressive symptoms at follow-up (OR: 
1.59; 95% CI, 1.15-2.19).  Mediation analyses revealed that low PA explained a total 
of 36.71% of the relationship between high CRP and elevated depressive symptoms, 
and 33.26% between higher levels of fibrinogen and elevated depressive symptoms 
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six years later.  No direct association was found between systemic low-grade 
inflammation and subsequently elevated depressive symptoms. 
Conclusion: These results suggest that low PA is a significant partial mediator of 
the relationship between systemic low-grade inflammation and subsequent elevated 
depressive symptoms in a nationally representative cohort of older adults. 
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1. INTRODUCTION 
Depression is a growing public health concern and a leading cause of disability 
worldwide, particularly among older adults (Mathers & Loncar, 2006).  Previous 
evidence suggests that approximately 18% of adults aged 65 years and older suffer 
from depression in England (Zivin et al., 2010).  Late-life depression has been linked 
to a wide range of adverse health outcomes, including an increased risk of morbidity 
(Frasure-Smith & Lespérance, 2003; Lee, Choi, & Lee, 2001; Meyers, 1996), 
cognitive decline (Jorm, 2000) and mortality (Alexopoulos, 2005; Blazer, 2003).  
However, the exact biological mechanisms underlying the pathogenesis of 
depression remain elusive (Franceschi & Campisi, 2014). 
One hypothesis that has been previously suggested for the aetiology of late-
life depression is the inflammation hypothesis of depression (Alexopoulos & 
Morimoto, 2011; Franceschi & Campisi, 2014).  This hypothesis posits that ageing 
shifts the body into a chronic proinflammatory state, based on an increased immune 
response in the peripheral nervous system (PNS), impaired immune communication 
between the PNS and the central nervous system (CNS) and a discordant and 
increased CNS response to inflammatory processes in the periphery (Franceschi & 
Campisi, 2014).  Furthermore, it suggests that these age-related biological changes 
can, in susceptible individuals, initiate the development of ‘sickness behaviour’ or 
depressive-like symptoms, such as fatigue, irritability, anhedonia and social 
withdrawal (Dantzer, O’Connor, Freund, Johnson, & Kelley, 2008).  Plausible 
biological pathways exist for the effects of systemic low-grade inflammation on 
mood, including the activation of the tryptophan-degrading enzyme indoleamine 2,3-
dioxygenase, the inhibition of serotonin synthesis, and the impairment of antioxidant 
defences (Valkanova et al., 2013). 
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Systemic low-grade inflammation describes the persistent production of 
proinflammatory factors, as opposed to an acute inflammatory state, in response to 
immune challenge (Pietzner et al., 2017).  Low-grade inflammation is typically 
measured via serum concentrations of circulating proinflammatory markers (e.g. the 
cytokines interleukin-8 (IL-8), interleukin-6 (IL-6), tumour necrosis factor α (TNF-α), 
the acute phase protein C-reactive protein (CRP) and the coagulation protein 
fibrinogen).  To date, prospective evidence supporting the depressogenic effect of 
systemic low-grade inflammation has yielded mixed results.  For example, a previous 
meta-analysis evaluated the cumulative evidence of eleven prospective cohort 
studies on the relationship between systemic inflammation and subsequent 
depressive symptoms (Valkanova et al., 2013).  Overall, the results revealed a 
significant association between high baseline levels of inflammatory markers (CRP 
and IL-6) and subsequent depressive symptoms (N=18,527).  However, only two of 
these studies assessed the inflammation-depression pathway in ageing cohorts 
(Stewart et al., 2009; van den Biggelaar et al., 2007), hampering the generalisability 
to the older population. 
Martínez-Cengotitabengoa et al. (2016) reviewed the longitudinal evidence of 
six studies focusing uniquely on older adults (≥ 60 years).  Five of these studies 
reported significant associations between IL-6, IL-8 or TNF-α and future depressive 
symptoms (Baune et al., 2012; Bremmer et al., 2008; Forti et al., 2010; Milaneschi et 
al., 2009; van den Biggelaar et al., 2007).  However, Stewart et al. (2009) found that 
neither baseline CRP nor IL-6 predicted depressive symptomatology six years later 
in a sample of 263 American older adults (≥ 50 years).  These results concur with the 
findings of another prospective investigation, which reported no significant 
associations between elevated levels of CRP and subsequent depressive symptoms 
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in 3,397 community-dwelling older adults (≥ 50 years) (Au et al., 2014).  Possible 
explanations for inconsistencies in findings include differences in the study design, 
study population and variability in measurements used to assess both low-grade 
inflammation and depressive symptoms (Martínez-Cengotitabengoa et al., 2016).  
Physical activity (PA) has been linked to both the regulation of the innate 
immune system and the treatment of depressive disorders.  For example, regular PA 
has been found to significantly reduce systemic inflammation in older adults (Hamer 
et al., 2009).  Moreover, people engaging in regular PA are less likely to develop 
future depressive symptoms (Hamer et al., 2009; Joshi et al., 2016; Ku et al., 2017; 
Mammen & Faulkner, 2013; Pasco et al., 2011; Roh et al., 2015; Yoshida et al., 
2015).  Hence, regular PA may play a central role in the maintenance of both mental 
and physical health.  However, until now, there have been no prospective studies 
examining whether PA acts as an intermediate mechanism in the relationship 
between systemic low-grade systemic inflammation and subsequent depressive 
symptoms.  Therefore, the present study aimed to assess whether low PA mediated 
the relationship between elevated serum levels of proinflammatory biomarkers (CRP 
and fibrinogen) and subsequent depressive symptoms in English community-
dwelling older adults, using prospective data from the English Longitudinal Study of 
Ageing (ELSA). 
1.1. Hypotheses 
It was hypothesised that: 
1. Higher baseline levels of inflammatory markers (CRP and fibrinogen) would 
be associated with elevated depressive symptoms at follow-up (path a, Figure 
1);  
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2. Low PA would mediate the association between higher levels of inflammatory 
markers and subsequent elevated depressive symptoms (path b*c, Figure 1). 
< Figure 1 here > 
2. METHOD 
2.1. Study Design  
ELSA is an ongoing, nationally representative, prospective cohort study of men and 
women aged ≥ 50 years living in England.  ELSA was established in 2002, using 
objective and subjective measures to assess the causes and consequences of 
health-related outcomes (Steptoe et al., 2012).  The original sample consisted of 
people born on/before 29th February 1952, who were recruited from English 
households in the context of the Health Survey for England (Sproston & Mindell, 
2006).  Participant selection was based on multistage stratified probability sampling, 
selecting postcode sectors at the first stage and household addresses at the second 
stage.  Since 2002, data collection has been conducted bi-annually.  Wave 4 
(2008/09) was considered as the baseline in the present study.  This wave includes 
a rich variety of psychosocial data collected via face-to-face computer-assisted 
personal interviews (CAPI) and biological data collected during nurse visits at 
participants’ homes (e.g. blood samples, body mass index, etc.).  The follow-up 
period reported here is wave 7 (2014/15), the latest wave of data collection available 
at the time of these analyses.  All participants provided written consent prior to their 
participation in the study.  Ethical approval was granted by the London Multi-Centre 
Research Ethics Committee (https://www.elsa-project.ac.uk). 
2.2. Analytical Sample  
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A total of 9,886 participants attended the core assessment at wave 4.  Participants 
with missing blood samples at baseline were omitted from the analytical sample 
(n=3,985).  Missing biological data were mainly due to participants’ unwillingness to 
consent or ineligibility to provide blood samples (e.g. due to clotting or bleeding 
disorders and/or use of anticoagulant medication).  Participants with baseline levels 
of CRP equal to or higher than 10mg/L were also excluded (n=411) as these 
concentrations indicate acute infection rather than systemic low-grade inflammation 
(Koenig et al., 1999).  Additionally, participants with elevated depressive symptoms 
at baseline and wave 6 were omitted from the present analysis (n=976).  Following 
further exclusion of participants with missing or invalid data (covariates, mediator 
and outcome; n=705), the final analytical sample consisted of 3,809 adults (see 
Figure 2 for the analytical sample flow-chart). 
< Figure 2 here > 
2.3. Measures 
2.3.1. Depressive symptoms at wave 7 (2014/15) 
Depressive symptoms were assessed using the 8-item version of the Centre for 
Epidemiological Studies Depression Scale (CES-D) (Radloff, 1977), which has been 
well validated in previous studies (Irwin et al., 1999; Lyness et al., 1997).  
Participants responded on a binary response scale (yes = 1; no = 0), indicating 
whether they had experienced a) low mood, b) low energy levels/effort doing things, 
c) enjoyment in life, d) sadness, e) loneliness and/or f) restless sleep during the past 
week. CES-D scores ranged from 0 (no depressive symptoms) to 8.  The total score 
was dichotomised, using a well-recognised cut-off value of ≥ 4 to indicate ‘elevated 
  
 
 
 
 
10 
depressive symptoms’ (Hamer et al., 2009; Steffick, 2000).  Cronbach’s alpha was 
0.68. 
 
2.3.2. C-reactive protein and fibrinogen at wave 4 (2008/09) 
Serum concentrations of CRP (mg/L) were analysed at the Royal Victoria Infirmary 
laboratory in Newcastle (UK), using the N Latex CRP mono Immunoassay on the 
Behring Nephelometer II Analyser (Graig et al., 2004).  CRP values were 
dichotomised, using a validated threshold of (≥ 3mg/L) to denote high levels of 
peripheral inflammation (Pearson et al., 2003). 
Fibrinogen (g/L) was analysed via the Clauss Thrombin clotting method on the 
Organon Teknika MDA 180 analyser (Graig et al., 2004).  Fibrinogen was treated as 
a continuous variable, with higher values indicating greater levels of systemic 
inflammation. 
2.3.3. Mediator at wave 6 (2012/13) 
Physical Activity 
Participants were asked to report how often they engaged in weekly mild, moderate 
and/or vigorous PA.  Response options included ‘hardly ever or never’, ‘one to three 
times a month’, ‘more than once a week’ and ‘once a week’.  Before answering these 
questions, participants were shown examples of activities on a card in order to help 
them to interpret PA types and intensities.  Examples of mild activities included home 
repairs and laundry; the moderate PA category included walking at a moderate pace, 
gardening, dancing, cleaning the car and floor or stretching exercises; vigorous 
intensity activities included swimming, tennis, digging with a spade, running/jogging, 
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aerobics/gym workout and cycling.  The present analysis used the item 
‘moderate/vigorous PA at least once a week’ as a measure of PA.  Responses were 
categorised into ‘high PA’ (moderate/vigorous PA at least once a week) versus ‘low 
PA’ (no weekly moderate/vigorous PA) based on the NHS guidelines for PA in adults 
(NHS, 2013).  PA scores were reversed, with a score of “0” indicating “high PA” and 
a score of “1” indicating “low PA”. 
2.3.4. Baseline covariates 
Sociodemographic variables 
Sociodemographic variables included age, sex, education and socio-economic 
position (SEP).  Education was measured by asking participants to report their 
highest attained educational qualification.  SEP was indexed by total household 
wealth, the most detailed and reliable indicator of SEP in ELSA (Marmot et al., 
2002).  The imputation of total household wealth was based on over 20 components 
of wealth and dept, which were either observed or computed during the CAPI.  
These included participants’ financial wealth (including investments and savings), the 
worth of any property, business assets, physical wealth (e.g. jewellery) and net of 
debt (including mortgage).  For a more detailed description of how household wealth 
was calculated, see Marmot et al. (2002).  In this study, total household wealth was 
divided into quintiles. 
Health-related variables 
Body Mass Index (BMI) was assessed during nurse visits at participants’ homes.  
BMI was calculated by deriving participants’ height and weight and subsequently 
using the standard formula (kg/m2). 
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Data on smoking were obtained by asking participants whether they had ever 
smoked.  Participants who responded positively were further queried to indicate 
whether they still smoke.  Responses were categorised into ‘no’ (never and past 
smoker) and ‘yes' (current smoker). 
 
Metabolic markers 
High-density lipoprotein (HDL) cholesterol and triglycerides were measured via blood 
samples collected during nurse visits at participants’ homes.  HDL cholesterol and 
triglycerides were measured with an Olympus 640 analyser using a direct method 
(no precipitation) and an enzymatic assay respectively (Graig et al., 2004).  The unit 
of measurement for both metabolic markers was mmol/L. 
2.4. Statistical Analyses 
Baseline characteristics of the study participants are reported as means and 
standard deviations (SD) for continuous variables and proportions for categorical 
variables.  Significant differences in means and proportions were tested via two-
sided t-tests and chi-square tests of independence respectively. 
Mediation assumes that the relationship between the independent variable 
(systemic low-grade inflammation) and the dependent variable (depressive 
symptoms) is mediated by a third variable (low PA).  The total effect refers to the 
effect of systemic low-grade inflammation on subsequent depressive symptoms.  
The indirect effect represents the amount of mediation exerted through low PA on 
the relationship between elevated levels of inflammatory markers and subsequent 
depressive symptoms.  The direct effect is defined as the effect of systemic low-
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grade inflammation on subsequent depressive symptoms while controlling for the 
mediator variable (Rucker et al., 2011). 
Mediation was assessed initially by fitting a series of multivariate regression 
models (see Figure 1).  First, multivariate logistic regression models were employed 
to test the associations between inflammatory markers (fibrinogen and CRP) and 
subsequent depressive symptoms respectively (step 1, Figure 1).  Second, the 
relationship between baseline levels of inflammatory markers and weekly 
moderate/vigorous PA was analysed (step 2, Figure 1).  All analyses (step 1 and 
step 2) were adjusted for age, sex, education, total household wealth, BMI, smoking, 
cholesterol and triglyceride levels.  Covariates were entered in a stepwise fashion 
(Model 1: adjusted for age and sex; Model 2: Model 1 & further adjusted for 
sociodemographic variables; Model 3: Model 2 & further adjusted for BMI and 
smoking; Model 4: Model 3 & further adjusted for metabolic factors).  Third, further 
multivariate logistic regression analyses were performed to test whether low PA at 
wave 6 was associated with elevated depressive symptoms at follow-up (step 3, 
Figure 1).  Analyses were independent of age, sex, baseline inflammatory markers, 
education, wealth, BMI, smoking, cholesterol and triglyceride levels.  The results of 
all multivariate regression analyses are presented as adjusted odds ratios (OR) with 
95% confidence intervals (CI). 
Previously, it was originally assumed that a significant total effect (i.e. step 1) 
was a necessary condition for establishing mediation (Baron & Kenny, 1986).  
However, it has since been widely agreed that mediation can occur in the absence of 
total or direct effect (Emsley et al., 2010; Goldsmith et al., 2018; Shrout & Bolger, 
2002).  For example, mediation may be present if the mediated and direct effect 
have opposing signs, i.e. the effects under investigation are in opposite directions.  
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Conceptually, our analysis anticipates that elevated baseline levels of 
proinflammatory markers will be associated with low PA at wave 6 but a higher 
incidence of depressive symptoms at wave 7.  Therefore, the conditions for 
mediation are satisfied. 
The significance of the indirect pathway, i.e. whether low PA explained the 
relationship between elevated levels of inflammatory markers and subsequent 
depressive symptoms was assessed using the binary mediation package for Stata.  
All mediation analyses were adjusted for age, sex, education, wealth, BMI, 
cholesterol and triglycerides.  Bootstrapping (1000 replications) was employed as a 
validated method to estimate the bias-corrected confidence intervals of the indirect 
effect (step 4) (Mackinnon, 2008).  All statistical analyses were conducted using 
STATA version 14.1. 
2.4.1 Sensitivity Analyses 
Three sensitivity analyses were conducted.  First, further mediation analyses were 
performed to investigate the indirect effect of low PA on the association between 
systemic inflammation and elevated depressive symptoms at follow-up, when 
additionally adjusting for sleep problems and diet at baseline (wave 4) 
(Supplementary Table S1).  Sleep problems and unhealthy dietary habits have both 
been implicated in the regulation of the innate immune system and the pathogenesis 
of depression (Baglioni et al., 2011; Irwin, Olmstead and Carroll, 2016; Lassale et al., 
2018).  Second, to further assess the temporal precedence in the relationship 
between systemic low-grade inflammation, PA and depressive symptoms, mediation 
models were re-estimated with adjustment for baseline levels of PA (Supplementary 
Table S2).  In addition, we conducted supplementary analyses to assess whether 
additionally accounting for baseline levels of PA may have resulted in a potential 
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over-adjustment.  Hence, we analysed the cross-sectional association between 
baseline levels of systemic inflammation and PA (Supplementary Table S3), as well 
as the prospective association between baseline PA and PA at wave 6 
(Supplementary Table S4).  Subsequently, we ran a McNemar’s test to assess 
whether there was a significant difference between participants’ PA levels at 
baseline and wave 6.  Stability of PA levels over time (i.e. baseline to wave 6) may 
indicate that accounting for baseline PA resulted in a potential over-adjustment of the 
model.  Third, given the possibility of collider bias (also known as endogenous 
selection bias) (Elwert & Winship, 2014), further mediation models were conducted, 
including participants with elevated depressive symptoms at baseline and wave 6 
(Supplementary Table S5). 
3. RESULTS 
3.1. Sample Characteristics  
Baseline characteristics of the sample (N = 3,809) are presented in Table 1.  The 
average age of participants was 64.59 ± 8.28 years.  Slightly more women (51.59%) 
than men (48.41%) participated in this study.  High baseline concentrations of CRP 
(≥ 3mg/L) were found in approximately 27% of participants.  The mean concentration 
of baseline fibrinogen was 3.28 ± 0.49 g/L.  Roughly 30% of the overall sample were 
categorised into the low PA group at wave 6. 
Excluded participants tended to be of older age (66.90 vs. 64.59 years; 
p<0.001), had a higher incidence of elevated baseline levels of CRP (30.26% vs. 
26.26%; p=0.018), fibrinogen (3.28 vs. 3.33 mg/L; p=0.004) and cholesterol (5.53 vs. 
5.65 mmol/L; p=0.002), and were less likely to have completed a university degree 
(16.67% vs. 21.92%; p<0.001).  They were also less likely to engage in weekly 
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moderate/vigorous PA at wave 6 (41.82% vs. 29.09%; p<0.001), and more likely to 
be in the lowest quintile of household wealth (17.60% vs. 11.08%; p<0.001) and 
current smokers (12.86% vs. 10.48%; p=0.027). 
< Table 1 here > 
3.2. Step 1: Inflammatory Markers and Depressive Symptoms  
The results of the hierarchical multivariate logistic regression models testing the 
association between higher baseline levels of inflammatory markers and depressive 
symptoms at a six years follow-up are presented in Table 2. 
< Table 2 here > 
C-reactive protein. Compared to participants with normal CRP levels at baseline, 
those with high CRP were not significantly more likely to subsequently develop 
elevated depressive symptoms at follow-up (Model 1: OR: 1.17; 95% CI, 0.85-1.61). 
Fibrinogen. Similarly, higher fibrinogen concentrations at baseline were unrelated to 
elevated depressive symptoms at follow-up, relative to lower baseline levels of 
fibrinogen (Model 1: OR: 1.14; 95% CI, 0.84-1.54). 
3.3. Step 2: Inflammatory Markers and Physical Activity  
The fully adjusted multivariate logistic regression models for the associations 
between inflammatory markers at baseline and low PA at wave 6 are presented in 
Table 3. 
< Table 3 here > 
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C-Reactive Protein. Participants with elevated levels of CRP at baseline had 
significantly higher odds of low PA at wave 6 (OR: 1.25; 95% CI, 1.05-1.48), relative 
to those with normal CRP levels. 
Fibrinogen. Participants with higher levels of fibrinogen also had significantly greater 
odds of low PA (OR: 1.18; 95% CI, 1.05-1.39), compared to those with lower levels 
of fibrinogen at baseline. 
3.4. Step 3: Physical Activity and Depressive Symptoms 
Table 4 displays the fully adjusted logistic regression models for the associations 
between low PA at wave 6 and depressive symptoms at wave 7. 
< Table 4 here > 
Low PA. Participants who did not engage in weekly moderate/vigorous PA were 
significantly more likely to report elevated depressive symptoms at follow-up, 
compared to physically active participants (model additionally adjusted for baseline 
CRP: OR: 1.59; 95% CI, 1.15-2.19; model additionally adjusted for baseline 
fibrinogen: OR: 1.59; 95% CI, 1.15-2.19). 
3.5. Step 4: Mediation Analyses 
Binary mediation analysis was performed to test whether low PA mediated the 
relationship between systemic low-grade inflammation and subsequently elevated 
depressive symptoms (see Table 5). 
C-reactive protein. Low PA significantly mediated the relationship between high CRP 
and subsequently elevated depressive symptoms (indirect effect: β = 0.010; 95% CI, 
0.001-0.022), explaining a total of 36.71% of this association.  Neither a significant 
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total (β = 0.019, 95% CI, -0.096-0.112) nor direct effect (β = 0.009, 95% CI, -0.101-
0.103) was found in this model. 
Fibrinogen. Low PA also acted as a partial mediator of the relationship between 
higher levels of fibrinogen and elevated depressive symptoms at follow-up, 
explaining a total of 33.27% (indirect effect: β = 0.005; 95% CI, 0.0003-0.0140).  No 
significant total (β = 0.016, 95% CI, -0.069-0.109) or direct effect (β = 0.011, 95% CI, 
-0.076-0.102) was found in this model. 
< Table 5 here > 
Figure 3 provides a summary of the mediation analyses conducted, using graphical 
illustrations. 
< Figure 3 here > 
3.6. Sensitivity Analyses 
Our first sensitivity analysis revealed similar results to those in our main analyses; 
low PA at wave 6 remained a significant mediator after additionally adjusting for 
sleep problems and dietary habits at baseline (wave 4) (Supplementary Table S1). 
Our second sensitivity analysis indicated that additionally adjusting for 
baseline levels of PA resulted in a non-significant indirect effect of low PA (wave 6) 
on the relationship between baseline levels of systemic low-grade inflammation and 
depressive symptoms at wave 7 (Supplementary Table S2).  Interestingly, our 
supplementary analyses suggest that this attenuation to statistical non-significance 
may be due to over-adjustment.  Higher levels of systemic inflammation were cross-
sectionally associated with low PA levels at baseline (Supplementary Table S3).  
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Moreover, PA levels at baseline were significantly associated with PA levels four 
years later (wave 6) (Supplementary Tables S4).  Furthermore, the results of the 
McNemar’s test showed that there was no significant difference between 
participants’ PA levels at baseline and wave 6 (p=0.64).  Therefore, additionally 
controlling for baseline levels of PA may have resulted in over-adjustment. 
Lastly, our third sensitivity analyses revealed that low PA at wave 6 continued 
to be a significant mediator after including participants with elevated depressive 
symptoms at baseline and wave 6 (Supplementary Table S5). 
 
4. DISCUSSION 
The present study investigated whether low PA mediated the relationship between 
higher serum levels of proinflammatory markers (CRP and fibrinogen) and 
subsequently elevated depressive symptoms in non-depressed English community-
dwelling older adults.  The present findings suggest that neither elevated baseline 
levels of CRP or fibrinogen are significantly associated with elevated depressive 
symptoms six years later.  This is in line with the results of two previous longitudinal 
studies (Au et al., 2014; Stewart et al., 2009).  For example, Au and colleagues 
(2014) assessed the prospective relationship between CRP and subsequent 
depressive symptoms (CES-D ≥ 4) in 3,397 ELSA participants.  The results indicated 
no evidence for a significant association between high baseline levels of CRP and 
elevated depressive symptoms at a six-year follow-up, after adjusting for metabolic 
and health-related variables. 
Interestingly, earlier studies repeatedly showed significant effects of TNF-α, 
IL-6, or IL-8 on subsequent depressive symptoms in adult populations (≥ 50 years) 
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(Forti et al., 2010; Milaneschi et al., 2009), but not for CRP or fibrinogen (Baune et 
al., 2012; Bremmer et al., 2008).  For instance, Baune et al. (2012) found that both 
IL-6 and IL-8, but not CRP, predicted the onset of depressive symptomatology two 
years later in a sample of 1,037 Australian older adults.  Similarly, Bremmer et al. 
(2008) reported that elevated baseline levels of IL-6, but not CRP or fibrinogen, were 
significantly associated with the onset of major depression 12 months later in 1,285 
Dutch adults, using the 20-item version of the CES-D and clinical interviews to 
assess depressive symptomatology.  Inconsistencies in findings may also be due to 
the lack of regard for persistency of repeated exposure to systemic low-grade 
inflammation (Bell et al., 2017; Kivimäki et al., 2014).  A recent epidemiological 
investigation examined whether repeated exposure to elevated levels of CRP (≥ 
3mg/L) increased the risk of developing future depressive symptoms, using 
prospective data from a population-based sample of adults aged 50 and older (Bell 
et al., 2017).  The results indicated that participants with elevated levels of CRP on 
only one occasion were not significantly more likely to develop depressive symptoms 
at follow-up compared to normal levels of CRP.  However, participants with 
increased plasma CRP on multiple occasions had significantly higher odds of 
developing depressive symptoms at follow-up, relative to those without elevated 
levels of systemic inflammation. 
To the best of our knowledge, this is the first study to demonstrate that weekly 
moderate/vigorous PA represents a significant partial mediator of the relationship 
between systemic low-grade inflammation and subsequently elevated depressive 
symptoms.  This coincides with previous literature suggesting that PA has a central 
role in both mental health and the regulation of peripheral inflammatory processes.  
Regular PA has consistently been associated with a lower risk of developing 
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depressive symptoms in people aged 50 years and older (Chang et al., 2017; Hamer 
et al., 2009; Joshi et al., 2016; Ku et al., 2017; Lindwall et al., 2011; Pasco et al., 
2011; Roh et al., 2015; Yoshida et al., 2015).  Moreover, previous studies suggested 
reciprocal links between systemic inflammation and PA (Abramson & Vaccarino, 
2002; Geffken et al., 2001; Hamer & Steptoe, 2007; Kasapis & Thompson, 2005).  In 
the present study, low PA was significantly associated with elevated depressive 
symptomatology two years later.  Moreover, elevated baseline levels of CRP and 
fibrinogen were significantly associated with low PA four years later.  Hence, our 
results suggest that people with elevated levels of systemic inflammation may be 
less likely to engage in weekly moderate or vigorous PA, which may increase the risk 
of developing elevated levels of depressive symptoms.  Importantly, PA explained 
approximately one-third of the total effect of systemic inflammation on subsequently 
elevated depressive symptoms. Future research is needed to identify other 
intermediate mechanisms explaining this relationship. 
Interestingly, our second sensitivity analysis revealed that additionally 
accounting for baseline levels of PA changed the indirect effect of low PA (wave 6) 
on the association between baseline levels of systemic inflammation and elevated 
depressive symptoms at wave 7 to statistical non-significance.  However, our 
supplementary analyses indicated that there was no significant difference between 
participants’ PA levels at baseline and wave 6.  This suggests that PA levels were 
likely to be stable over time in the present sample.  Hence, additionally adjusting for 
baseline levels of PA may have resulted in over-adjustment, potentially explaining 
the statistically non-significant indirect effect of low PA.  In sum, our findings 
contribute to the notion that regular PA may not only be a valuable tool in preventing 
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subsequent depressive symptoms but may also have a potential anti-inflammatory 
role. 
4.1. Biological Mechanisms 
The exact biological mechanisms linking inflammatory processes to depressive 
symptoms through the effects of PA are not entirely known.  However, it has been 
suggested that systemic low-grade inflammation and PA act on the same effector 
systems of the body: the hypothalamic pituitary adrenal axis (HPA-axis) and the 
sympathetic nervous system (SNS) (Cotman, Berchtold & Christie, 2007; Irwin, 
Olmstead, & Carroll, 2016).  For example, elevated levels of proinflammatory 
cytokines have repeatedly been related to the hyperactivation of the HPA-axis, 
hypersecretion of stress hormones (e.g. cortisol), impaired serotonin and dopamine 
production, as well as the initiation of oxidative stress (Irwin et al., 2016).  Moreover, 
regular PA has been found to increase the body’s serotonin synthesis, improve the 
noradrenergic neurotransmission, trigger the release of endorphins, and reduce 
chronically increased SNS activity (Cotman et al., 2007; Meeusen & De Meirleir, 
1995).  PA has also been linked to increases in muscle-derived IL-6, which, in this 
context, can act as an anti-inflammatory myokine by inhibiting TNF-α (Pedersen, 
2017).  More importantly, these shared biological mechanisms have been found to 
play a major role in the pathophysiology of depression neurotransmitters (Franceschi 
& Campisi, 2014). 
4.2. Strengths and Limitations 
This study has a number of strengths, including the large sample size, the 
prospective study design, as well as the statistical methods employed to examine 
potential mediating mechanisms of low PA in the temporal relationships between 
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inflammatory markers and subsequent depressive symptoms.  Moreover, as far as 
we are aware, this is the first study to date which has explored this mediating 
mechanism in a large representative sample of English older adults. 
However, findings need to be interpreted in light of several limitations.  First, 
the measure of PA was based on self-report rather than objective methods, bearing 
the risk of self-report bias.  Second, our PA measure was based on a single-item 
question focusing on the frequency rather than the duration of weekly moderate or 
vigorous PA.  Third, PA ratings may have been influenced by psychosocial factors, 
such as mood or socioeconomic circumstances.  To address this issue, participants 
with elevated depressive symptoms at baseline and four years post-baseline were 
excluded from the analytical sample.  Moreover, all analyses were adjusted for 
education and wealth.  Lastly, the generalisability of the present findings is limited to 
older Caucasian adults only, since the ELSA population is largely comprised of white 
participants. 
4.3. Implications 
Taken together, the present findings suggest that low PA is a significant partial 
mediator of the relationship between systemic low-grade inflammation and 
subsequent depressive symptomatology – lending support to the second hypothesis 
of this study.  Hence, systemic low-grade inflammation is likely to represent an 
indirect risk factor for the development of new depressive symptoms through the 
mechanism of low PA.  This finding may have implications for clinicians and 
healthcare providers since PA represents a modifiable health behaviour.  As such, 
targeting systemic low-grade inflammation via tailored interventions (e.g. exercise) 
may be an effective way to treat adults with elevated depressive symptoms. 
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Evidence suggests that even low levels of physical exercise (e.g. walking less 
than 150 minutes per week) significantly reduce the risk of developing future 
depressive symptoms by 8% to 63% (Ball et al., 2009; Brown, Ford et al., 2005; 
Jonsdottir et al., 2010).  Accordingly, regular PA (three sessions per week; 45-60 
minutes over a period of 10 to 14 weeks) has been included in the clinical guidelines 
of the National Institute for Health and Care Excellence (NICE) for the treatment of 
mild to moderate depression (NICE, 2009).  Targeting insufficient PA may alleviate 
not only depressive symptomatology but also reduce chronically elevated levels of 
peripheral inflammation – thus diminishing the risk of developing other inflammatory 
diseases (e.g. cardiovascular diseases). 
4.4. Conclusion 
In conclusion, this study revealed that low PA significantly mediated the relationship 
between systemic low-grade inflammation and subsequently elevated depressive 
symptoms in community-dwelling older adults.  
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FIGURE TITLES 
Figure 1.  Hypothesised mediation model 
Figure 2.  Participant flow-chart ELSA cohort 
Figure 3.  Mediation models of the relationship between elevated baseline levels  
of inflammatory biomarkers and subsequent depressive symptoms 
mediated by low physical activity 
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Figure 1: Hypothesised mediation model 
 
 
 
 
 
 
 
 
 
Hypothesised mediation models: a = direct effect; b*c = indirect effect; d = total effect; b*c + d = sum of indirect and direct effect  
Step 1 = Inflammatory markers in relation to depressive symptoms 
Step 2 = Inflammatory markers in relation to mediator variable (PA) 
Step 3 = Mediator variables in relation to depressive symptoms 
 
Inflammatory biomarkers 
a (step 1) 
Depressive symptoms 
d 
Low physical activity 
c (step 3) b (step 2) 
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Figure 2: Analytical Sample Flow-Chart 1 
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Missing blood samples (wave 4, 2008/09)  
(n=3,985) 
Core participants at baseline (wave 4, 2008/09) 
N = 9,886 
Main analytical sample 
N = 3,809 
Exclusion of participants with missing 
outcome data (n=648) 
Core participants with no missing exposure  
N = 5,901 
Exclusion of individuals with depressive symptoms 
at wave 4 (2008/09) and wave 6 (2012/13) 
Wave 4 (n=674) 
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Missing covariates: 
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Figure 3: Mediation models of the relationship between elevated baseline levels of inflammatory biomarkers and subsequent 
depressive symptoms mediated by low physical activity 
Model 1: Effect of elevated levels of CRP  
on subsequent depressive symptoms  
through low PA (b*c = 0.006; 95% CI,  
0.001-0.014) 
 
 
 
 
 
Model 2: Effect of elevated levels of  
fibrinogen on subsequent depressive  
symptoms through physical inactivity   
(b*c = 0. 005; 95% CI, 0. 0003-0.0140) 
 
 
Note. * = p < 0.05; ** = p < 0.005; numbers = Odds ratio (OR) 
High CRP 
b = 1.25*  c = 1.59** 
a = 1.07 
Depressive 
symptoms 
Low PA 
Fibrinogen 
b = 1. 18* c = 1.59**  
a = 1.05 
Depressive 
symptoms 
Low PA 
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Table 1: Descriptive characteristics of the sample at baseline (2008/09), follow-up 
(2014/15) and wave 6 (2012/13) (N = 3,809) 
Note: Number (percentage) and mean (standard deviation) 
  
Age (mean ± SD)  64.59 ± 8.28 
Sex 
    Men 
    Women 
  
1,844 (48.41%) 
1,965 (51.59%) 
Elevated depressive 
symptoms at wave 7 
(CES-D ≥ 4) 
 
 
186 (4.88%) 
C-reactive protein (mg/L) 
    Elevated 
    Normal 
  
1,014 (26.62%) 
2,795 (73.38%) 
Fibrinogen (g/L)  3.28 ± 0.49 
Moderate or vigorous 
physical activity (wave 6)  
    Yes 
    No 
  
 
2,701 (70.91%) 
1,108 (29.09%) 
Education 
    University 
degree/equivalent 
    Less than university 
    No qualification 
  
785 (21.60%) 
2,189 (56.48) 
835 (21.92%) 
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Table 1 (continued): Descriptive characteristics of the sample at baseline 
(2008/09), follow-up (2014/15) and wave 6 (2012/13) (N = 3,809) 
Wealth (quintiles) 
    Lowest quintile  
    2nd quintile  
    3rd quintile  
    4th quintile  
    Highest quintile  
BMI 
    Underweight 
    Normal 
    Overweight 
    Obese 
Current smoker  
    Yes  
    No 
Cholesterol (mmol/L) 
Triglyceride (mmol/L) 
  
422 (11.08%) 
641 (16.83%) 
779 (20.45%) 
879 (23.08%) 
1,088 (28.56%) 
 
21 (0.55%) 
1,038 (27.25) 
1,706 (44.79%) 
1,044 (27.41%) 
 
399 (10.48%) 
3,410 (89.52%) 
5.65 ± 1.17 
1.70 ± 1.00 
Note: Number (percentage) and mean (standard deviation 
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Table 2: Association between high CRP/fibrinogen (2008/09) and depressive symptoms at follow-up (2014/15) N = 3,809 
Model   Elevated depressive symptoms (CES-D ≥ 4)  
  Adjusted odds ratio (95% CI) P-value 
Model 1 
    CRP 
    Fibrinogen 
  
1.17 (0.85, 1.61) 
1.14 (0.84, 1.54) 
 
0.345 
0.407 
Model 2  
    CRP 
    Fibrinogen 
  
1.10 (0.79, 1.52) 
1.07 (0.79, 1.46) 
 
0.573 
0.658 
Model 3 
    CRP 
    Fibrinogen 
  
1.08 (0.77, 1.52) 
1.04 (0.76, 1.42) 
 
0.639 
0.818 
Model 4 
    CRP  
    Fibrinogen 
  
1.07 (0.76, 1.51) 
1.05 (0.76, 1.44) 
 
0.687 
0.776 
All analyses were adjusted for age, sex, education, wealth status, BMI, smoking, cholesterol and triglycerides. 
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Table 3: Associations between baseline inflammatory markers (2008/09) and low physical activity at wave 6 (2012/13) 
Inflammatory markers Low Physical Activity 
N = 3,809 
 Odds Ratio 
(95% CI) 
P-value 
CRP (≥ 3 mg/L) 1.25 (1.05, 1.48) 0.010 
Fibrinogen (g/L) 1.18 (1.01, 1.39) 0.035 
All analyses were adjusted for age, sex, education, wealth status, BMI, smoking, cholesterol and triglycerides. 
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Table 4: Associations between low PA at wave 6 (2012/13) and depressive symptoms at follow-up (2014/15) 
Mediators  Elevated depressive symptoms (CES-D ≥ 4) 
N = 3,809 
  Odds ratio 
(95% CI) 
P-value 
Low physical activity 
    Model 1 
    Model 2 
 
 
 
1.59 (1.15, 2.19) 
1.59 (1.15, 2.19) 
 
0.005 
0.005 
Model 1: adjusted for age, sex, education, wealth status, BMI, smoking, cholesterol, triglycerides & baseline CRP; Model 2: 
adjusted for age, sex, education, wealth status, BMI, smoking, cholesterol, triglycerides & baseline fibrinogen. 
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Table 5: Mediation of the association between baseline inflammatory markers (wave 4, 2008/09) and depressive symptoms at 
follow-up (wave 7, 2014/15) through low physical activity at wave 6 (2012/13) (N = 3,809) 
Independent variable 
(wave 4) 
Mediator 
(wave 6) 
Outcome 
(wave 7) 
Total indirect 
effect  
Total effect  Total direct 
effect  
Total effect 
mediated 
   
 Coefficient 
(Bc CI*) 
Coefficient 
(Bc CI) 
Coefficient 
 (Bc CI) 
% 
 
CRP Low PA Depressive symptoms 0.010  
(0.001, 0.022) 
0.019  
(-0.096-0.112) 
0.009 
(-0.101, 0.103) 
36.71% 
Fibrinogen Low PA Depressive symptoms 0.005 
(0.0003, 0.0140) 
0.016 
(-0.069, 0.109) 
0.011 
(-0.076, 0.102) 
33.27% 
All analyses adjusted for age, sex, sociodemographic variables (education, wealth status), BMI, smoking, metabolic factors 
(cholesterol and triglycerides). 
* Bc CI = Bias corrected 95% confidence intervals 
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SUPPLEMENTARY ANALYSES 
Table S1. Mediation of the association between baseline inflammatory markers 
(wave 4, 2008/09) and depressive symptoms at follow-up (wave 7, 
2014/15) through low physical activity at wave 6 (2012/13), additionally 
adjusted for sleep problems and dietary habits (N = 3,160) 
Table S2. Mediation of the association between baseline inflammatory markers  
(wave 4, 2008/09) and depressive symptoms at follow-up (wave 7,  
2014/15) through low physical activity at wave 6 (2012/13) (N = 3,809),  
additionally adjusted for baseline PA levels 
Table S3. Cross-sectional association between levels of inflammatory markers 
and low physical activity at baseline (wave 4, 2008/2009) 
Table S4. Prospective association between baseline low physical activity (wave 
4, 2008/09) and low physical activity at wave 6 (2012/13) 
Table S5. Mediation of the association between baseline inflammatory markers  
(wave 4, 2008/09) and depressive symptoms at follow-up (wave 7,  
2014/15) through low physical activity at wave 6 (2012/13), including  
people with depressive symptoms at wave 4 and wave 6 (N = 4,435)
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Sensitivity Analysis (I)  
For the purpose of our first sensitivity analysis, the CES-D item on “restless sleep” 
was omitted to avoid shared variance when additionally adjusting for sleep problems.  
A validated threshold of ≥ 3 was used, representing “elevated depressive symptoms” 
(Steffick, 2000; White et al., 2016). 
 Moreover, we included sleep problems and dietary habits as additional 
covariates.  These health-related covariates were measured as follows:  
Sleep problems 
Sleep problems were measured via three items of the Jenkins Sleep Problems 
Scale, referring to the most common sleep complaints (difficulty falling asleep, 
difficulty staying asleep, and morning tiredness) (Jenkins et al., 1988).  Items were 
rated on a four-point Likert scale ranging from 1 to 4 (1 = not during the last month; 2 
= less than once a week; 3 = once or twice a week; 4 = three or more times a week).  
An average summary score was created and subsequently divided into quartiles.  
Scores in the fourth quartile were classified as disturbed sleep (Kumrai et al., 2008).  
For the present study, the variable sleep disturbance was dichotomised.  Responses 
were categorised into ‘no sleep problems’ for scores in the lower three quartiles and 
‘sleep problems’ for scores in the highest quartile. 
Dietary habits  
Dietary habits were measured by assessing participants’ daily fruit and vegetable 
intake.  Participants were asked to indicate whether they consumed at least 5 
portions of fruit/vegetables per day.  Responses were categorised into ‘yes’ (≥ 5 
portions of fruit/vegetables per day) and ‘no’ (< 5 portions of fruit/vegetables per day 
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Table S1: Mediation of the association between baseline inflammatory markers (wave 4, 2008/09) and depressive symptoms at 
follow-up (wave 7, 2014/15) through low physical activity at wave 6 (2012/13), additionally adjusted for sleep problems and dietary 
habits (N = 3,160) 
Independent variable 
(wave 4) 
Mediator 
(wave 6) 
Outcome 
(wave 7) 
Total indirect 
effect  
Total effect  Total direct 
effect  
Total effect 
mediated 
   
 Coefficient 
(Bc CI*) 
Coefficient 
(Bc CI) 
Coefficient 
 (Bc CI) 
% 
 
CRP Low PA Depressive symptoms 
(CES-D 7-item version) a 
0.007 
(0.001, 0.016) 
0.011 
(-0.083, 0.092) 
0.004 
(-0.092, 0.086) 
65.83% 
 
Fibrinogen Low PA Depressive symptoms 
(CES-D 7-item version) a 
0.007 
(0.001, 0.016) 
0.020 
(-0.066, 0.112) 
0.013 
(-0.073, 0.103) 
34.03% 
 
All analyses adjusted for age, sex, sociodemographic variables (education, wealth status), BMI, dietary habits, sleep problems, 
smoking, metabolic factors (cholesterol and triglycerides). 
* Bc CI = Bias corrected 95% confidence intervals 
a Elevated depressive symptoms = CES-D ≥ 3; CES-D item on ‘restless sleep’ excluded to avoid shared variance   
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Sensitivity Analysis (II) 
Table S2: Mediation of the association between baseline inflammatory markers (wave 4, 2008/09) and depressive symptoms at 
follow-up (wave 7, 2014/15) through low physical activity at wave 6 (2012/13) (N = 3,809), additionally adjusted for baseline PA 
levels 
Independent variable 
(wave 4) 
Mediator 
(wave 6) 
Outcome 
(wave 7) 
Total indirect 
effect  
Total effect  Total direct 
effect  
Total effect 
mediated 
   
 Coefficient 
(Bc CI*) 
Coefficient 
(Bc CI) 
Coefficient 
 (Bc CI) 
% 
 
CRP Low PA Depressive symptoms 0.004  
(-0.0004, 0.011) 
0.006  
(-0.081-0.091) 
0.010 
(-0.078, 0.096) 
- 
 
Fibrinogen Low PA Depressive symptoms 0.003 
(-0.0006, 0.010) 
0.008 
(-0.076, 0.096) 
0.011 
(-0.072, 0.099) 
- 
 
All analyses adjusted for age, sex, sociodemographic variables (education, wealth status), BMI, smoking, metabolic factors 
(cholesterol and triglycerides), and baseline PA levels. 
* Bc CI = Bias corrected 95% confidence intervals 
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Table S3: Cross-sectional association between inflammatory markers and low physical activity at baseline (wave 4, 2008/2009) 
Inflammatory markers Low Physical Activity 
N = 3,809 
 Odds Ratio 
(95% CI) 
P-value 
CRP (≥ 3 mg/L) 1.37 (1.16, 1.62) < 0.001 
Fibrinogen (g/L) 1.32 (1.12, 1.54) 0.001 
All analyses were adjusted for age, sex, baseline PA, education, wealth status, BMI, smoking, cholesterol and triglycerides. 
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Table S4: Prospective association between baseline low physical activity (wave 4, 2008/09) and low physical activity at wave 6 
(2012/13) 
 Low Physical Activity (wave 6) 
N = 3,809 
 Odds Ratio 
(95% CI) 
P-value 
Low Physical Activity (baseline) 3.01 (2.56, 3.54) < 0.001 
All analyses were adjusted for age, sex, education, wealth status, BMI, smoking, cholesterol and triglycerides. 
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Sensitivity Analysis (III) 
Table S5: Mediation of the association between baseline inflammatory markers (wave 4, 2008/09) and depressive symptoms at 
follow-up (wave 7, 2014/15) through low physical activity at wave 6 (2012/13), including people with depressive symptoms at wave 
4 and wave 6 (N = 4,435) 
Independent variable 
(wave 4) 
Mediator 
(wave 6) 
Outcome 
(wave 7) 
Total indirect 
effect  
Total effect  Total direct 
effect  
Total effect 
mediated 
   
 Coefficient 
(Bc CI*) 
Coefficient 
(Bc CI) 
Coefficient 
 (Bc CI) 
% 
 
CRP Low PA Depressive symptoms 0.009 
(0.002, 0.017) 
0.037 
(-0.021, 0.089) 
0.028 
(-0.027, 0.079) 
24.16% 
 
Fibrinogen Low PA Depressive symptoms 0.010 
(0.003, 0.017) 
0.018 
(-0.036, 0.075) 
0.008 
(-0.045, 0.067) 
54.85% 
 
All analyses adjusted for age, sex, sociodemographic variables (education, wealth status), BMI, smoking, metabolic factors 
(cholesterol and triglycerides). 
* Bc CI= Bias corrected 95% confidence intervals 
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